Business Wire

Approaching the 15th Anniversary of its LITE (Low Impact To the Environment) Concept, ISA TanTec Sets New Standards in Sustainable and Ecological Leather Production

Del

ISA is an eco-friendly leading leather manufacturer represented by the LITE Trademark. Together with ITG-Environmental Technology, the company established its LITE branded technology in 2003. The concept of LITE, which stands for “Low Impact To the Environment”, has attained international environmental standard recognition through the years.

Since 2012, in addition to the substantial reduction in electricity consumption and CO2 emissions, ISA has achieved more than a 50% reduction in fresh water consumption against the LWG benchmark in its facilities.

Numerous environmental solutions including: inter process recycling system, hydraulic cooling system, resource preserving finishing application, slow spinning drums, engineered constructed wetlands, solar energy, rainwater collection, windmill and waste management have been in place in ISA’s facilities. These measures ensure a high standard and ongoing improvement of environmental sustainability in the manufacturing process.

“We knew that controlling the greenhouse effect is a major ecological issue for future generations back in 1990s.” said Tom Schneider, Executive Chairman. “In 2003, we incorporated the first controlled wetlands in Saigon at our Saigon TanTec location, and are continually working on ways to reduce emissions by saving water and energy. We believe our LITE concept can be an inspiration to others and we have had several delegations visiting our tanneries to learn from the LITE production methods” he added.

In 2017, the savings per year was approximately 68% in water and 70% in energy against the industry’s benchmark (LWG 6.4 Pass Score, 50%). Among the tanneries in the USA, Vietnam and China, the average daily water savings was more than 2,375,000 liters. Given that the daily water consumption per person in India is 25 liters, the daily water saved by our company could support a city in India with more than 95,000 people. Considering the daily water uses i.e. toilet, shower, cooking, washing and cleaning (agriculture and industrial usage excluded).

ISA saved more than 107,187,000 kwh of energy in 2017. The average person in the world uses approximately 20,800 kWh energy per year. Therefore the energy ISA saved per year was sufficient to support more than 5,000 people worldwide for their daily energy needs.

ISA is approaching the 15th anniversary of its LITE Trademark. Integrated energy and environmental management as well as innovative technology will continue to be the key factors ISA considers in the future production plan of the company.

Contact information

ISA TanTec Limited
Gillian Tang
Marketing Manager
Tel. no (Macau): +853-6263-0008
Fax no.: +853-2835-6319
or
Heshan Bestway Leather Product Ltd.
Everson De Lima Rodrigues
Environmental Manager
Tel. no (China): +86-138-2706-0667
Fax no.: +86-750-8313288

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Asuragen to Launch the AmplideX® PCR/CE DMPK Kit and Present Growing Genetic Testing Portfolio at 2018 European Society of Human Genetics (ESHG) Conference22.5.2018 12:00Pressemelding

Asuragen, Inc., a molecular diagnostics company delivering high-quality, easy to use products for complex testing in genetics and oncology, today announced the launch of the AmplideX® PCR/CE DMPK Kit* to simplify analysis of repeat expansions within the DMPK gene, which is implicated in myotonic dystrophy type I (DM1), also known as Steinert’s disease. DM1 is an inherited form of muscular dystrophy that affects the muscles as well as multiple other organ systems, and its severity is largely determined by the size of the CTG trinucleotide repeat expansion within the DMPK gene. These expansions commonly extend beyond a thousand CTG repeats and therefore have required the use of cumbersome Southern blot technology to estimate their size. “The AmplideX DMPK Kit represented a significant improvement over our existing process for analyzing large DMPK expansions,” said Doctor Sophie Rondeau, PharmD, PhD, and Professor Jean-Paul Bonnefont, MD, PhD, of the Necker-Enfants Malades Hospital in Par

Phil Brakewell Set to Lead WilsonHCG's Executive Search Efforts Across EMEA; Forbes Ranks WilsonHCG Among Best Executive Recruiting Firms22.5.2018 12:00Pressemelding

WilsonHCG, global leader and premium provider of innovative talent solutions, further expands its Executive Search division with the appointment of Director Phil Brakewell. Phil, who brings more than 14 years of talent acquisition leadership experience and most recently served as Head of Executive Search for ResourceBank, will be responsible for leading WilsonHCG’s efforts in the EMEA region. Prior to joining ResourceBank, Phil held consultant and resourcing leadership positions at Hitchenor Wakeford and The Caudwell Group – where he was responsible for developing the business internationally and drove innovative search solutions on behalf of a diverse range of clients. “WilsonHCG’s reputation speaks for itself,” said Phil. “WilsonHCG tailors its key service offerings – including Executive Search – to suit individual client needs, and I am thrilled to be part of such a dedicated, innovative team. The new Director position, covering EMEA, demonstrates our commitment to both Executive Se

Celgene to Present New and Updated Data across a Range of Blood Diseases at EHA 201822.5.2018 11:30Pressemelding

Celgene Corporation (NASDAQ:CELG) today announced that data from a broad range of early and late stage studies evaluating Celgene investigational agents and investigational uses of marketed products will be presented at the 23rd European Hematology Association (EHA) annual meeting in Stockholm, Sweden, from June 14-17, 2018. "We are proud to be sharing new and updated data around our innovative hematological therapies at EHA 2018, which further our understanding of blood cancers and other blood-related diseases and allow us to continue to have a major impact on the lives of patients," said Nadim Ahmed, President, Hematology & Oncology Franchise. "The data presented at EHA underscore the important role of immunomodulatory drugs at various stages of multiple myeloma, as well as illustrate our ongoing work in developing innovative treatment options, such as our erythroid maturation agent and CAR T cell therapies, for patients with life threatening blood disorders and cancers." At EHA this

New Research from Displaydata and Planet Retail RNG Estimates That Global Retailers Spent $104 Billion on Manually Changing Price Labels in 201722.5.2018 11:02Pressemelding

New research launched today by Displaydata and Planet Retail RNG reveals that inaccurate, inconsistent pricing – and a lack of digital technology in-store – is costing retailers in lost sales and consumer trust, as price-conscious shoppers seek out the best deal and better experiences online. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180522005419/en/ According to a new report from Displaydata and Planet Retail RNG, over two thirds of shoppers want technologies that enhance their experiences in stores. 33% want promotions sent direct to their mobile devices; 31% want Electronic Shelf Labels (ESLs) to show accurate, real-time prices, promotions, and detailed product information; and 27% want to be identified as a loyal customer. (Photo: Business Wire) The research report, Analogue to Automated: Retail in the Connected Age – which surveyed 5000 consumers and 1000 retailers – sought to understand what consumers want from ph

Now, officially Cool! Price f(x) named “Gartner® Cool Vendor in Digital Commerce”22.5.2018 10:01Pressemelding

Price f(x), a leader in Price Optimization & Management SaaS, has been named a “Cool Vendor in Digital Commerce” in the 2018 report by Gartner®, Inc.1 This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180522005662/en/ Price f(x) is the pioneer of native Price Optimization & Management SaaS (“PO&M SaaS”) offering uniquely flexible, functionally broad and fast to implement solutions. In the report, Gartner® highlights Price f(x) as a true disruptor in this software segment through uncompromised customer-centric approach best reflected in the commercial offering of Pricing-as-a-Service (“PraaS™”). “We are devoted to simplicity, relevance and agility, but most importantly to commercial fairness. Our solution is designed, both technically and commercially, to quickly provide value to companies of any size, in any industry, in B2B, B2C as well as B2B2C. And offering all of that entirely free of implementation costs in our PraaS™ offe

Large-Scale Body Composition Study Reveals Link between Specific Fat Distributions and Metabolic Diseases22.5.2018 08:16Pressemelding

Specific patterns of fat distribution are linked to the presence of Coronary Heart Disease (CHD) and Type 2 Diabetes (T2D), according to a new study published in Obesity. 1 AMRA, the international leader in body composition analysis, today announced the results of a body composition study of over 6,000 subjects, stressing the need to measure and investigate several fat compartments in order to understand and develop treatments for multiple metabolic diseases. The new findings go far beyond what can be described by sex, age, lifestyle, BMI, or a single fat compartment, and have the potential to strongly impact how metabolic conditions will be prevented and managed in the future. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180522005616/en/ The Obesity study was co-authored in collaboration between AMRA, Pfizer, Westminster University, Linköping University, and UK Biobank. The 6,000 subjects analyzed are part of the UK Bioba